APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crizotinib Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Crizotinib Capsules Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchCrizotinib Capsules Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Crizotinib Capsules Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Crizotinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crizotinib Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Crizotinib Capsules Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Crizotinib Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Crizotinib Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Crizotinib Capsules market include Chia Tai Tianqing Pharmaceutical Group, Cipla Limited, Glenmark Pharmaceuticals, Natco Pharma, Pfizer, Jiangsu Hengrui Medicine and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Crizotinib Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Crizotinib Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Crizotinib Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crizotinib Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Crizotinib Capsules Segment by Company

Chia Tai Tianqing Pharmaceutical Group

Cipla Limited

Glenmark Pharmaceuticals

Natco Pharma

Pfizer

Jiangsu Hengrui Medicine

Qilu Pharmaceutical

Crizotinib Capsules Segment by Type

200mg

250mg

Crizotinib Capsules Segment by Application

Hospital

Clinic

Others

Crizotinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Crizotinib Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Crizotinib Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Crizotinib Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Crizotinib Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crizotinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crizotinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crizotinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Crizotinib Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Crizotinib Capsules industry.

Chapter 3: Detailed analysis of Crizotinib Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Crizotinib Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Crizotinib Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Crizotinib Capsules Industry Trends Table 2. Crizotinib Capsules Industry Drivers Table 3. Crizotinib Capsules Industry Opportunities and Challenges Table 4. Crizotinib Capsules Industry Restraints Table 5. Global Crizotinib Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Crizotinib Capsules Revenue Share by Company (2021-2026) Table 7. Global Crizotinib Capsules Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Crizotinib Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Crizotinib Capsules Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Crizotinib Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Crizotinib Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Crizotinib Capsules Company, Product Type & Application Table 13. Global Crizotinib Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Crizotinib Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 200mg Table 18. Significant Companies of 250mg Table 19. Global Crizotinib Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Crizotinib Capsules Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Crizotinib Capsules Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Crizotinib Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Crizotinib Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Crizotinib Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Crizotinib Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Crizotinib Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Crizotinib Capsules Sales Value Share by Type (2021-2026) Table 28. Global Crizotinib Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Crizotinib Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Crizotinib Capsules Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Crizotinib Capsules Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Crizotinib Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Crizotinib Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Crizotinib Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Crizotinib Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Crizotinib Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Crizotinib Capsules Sales Value Share by Application (2021-2026) Table 41. Global Crizotinib Capsules Sales Value Share by Application (2027-2032) Table 42. Global Crizotinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Crizotinib Capsules Sales by Region (2021-2026) & (Tons) Table 44. Global Crizotinib Capsules Sales Market Share by Region (2021-2026) Table 45. Global Crizotinib Capsules Sales by Region (2027-2032) & (Tons) Table 46. Global Crizotinib Capsules Sales Market Share by Region (2027-2032) Table 47. Global Crizotinib Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Crizotinib Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Crizotinib Capsules Sales Value Share by Region (2021-2026) Table 50. Global Crizotinib Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Crizotinib Capsules Sales Value Share by Region (2027-2032) Table 52. Global Crizotinib Capsules Market Average Price (US$/Ton) by Region (2021-2026) Table 53. Global Crizotinib Capsules Market Average Price (US$/Ton) by Region (2027-2032) Table 54. Global Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Crizotinib Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Crizotinib Capsules Sales by Country (2021-2026) & (Tons) Table 57. Global Crizotinib Capsules Sales Market Share by Country (2021-2026) Table 58. Global Crizotinib Capsules Sales by Country (2027-2032) & (Tons) Table 59. Global Crizotinib Capsules Sales Market Share by Country (2027-2032) Table 60. Global Crizotinib Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Crizotinib Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Crizotinib Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Crizotinib Capsules Sales Value Market Share by Country (2027-2032) Table 64. Chia Tai Tianqing Pharmaceutical Group Company Information Table 65. Chia Tai Tianqing Pharmaceutical Group Business Overview Table 66. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio Table 68. Chia Tai Tianqing Pharmaceutical Group Recent Development Table 69. Cipla Limited Company Information Table 70. Cipla Limited Business Overview Table 71. Cipla Limited Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Cipla Limited Crizotinib Capsules Product Portfolio Table 73. Cipla Limited Recent Development Table 74. Glenmark Pharmaceuticals Company Information Table 75. Glenmark Pharmaceuticals Business Overview Table 76. Glenmark Pharmaceuticals Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio Table 78. Glenmark Pharmaceuticals Recent Development Table 79. Natco Pharma Company Information Table 80. Natco Pharma Business Overview Table 81. Natco Pharma Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Natco Pharma Crizotinib Capsules Product Portfolio Table 83. Natco Pharma Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Pfizer Crizotinib Capsules Product Portfolio Table 88. Pfizer Recent Development Table 89. Jiangsu Hengrui Medicine Company Information Table 90. Jiangsu Hengrui Medicine Business Overview Table 91. Jiangsu Hengrui Medicine Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio Table 93. Jiangsu Hengrui Medicine Recent Development Table 94. Qilu Pharmaceutical Company Information Table 95. Qilu Pharmaceutical Business Overview Table 96. Qilu Pharmaceutical Crizotinib Capsules Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Qilu Pharmaceutical Crizotinib Capsules Product Portfolio Table 98. Qilu Pharmaceutical Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Crizotinib Capsules Distributors List Table 102. Crizotinib Capsules Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Crizotinib Capsules Product Image Figure 2. Global Crizotinib Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crizotinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Crizotinib Capsules Sales (2021-2032) & (Tons) Figure 5. Global Crizotinib Capsules Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Crizotinib Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 200mg Image Figure 10. 250mg Image Figure 11. Global Crizotinib Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Crizotinib Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Crizotinib Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Crizotinib Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Crizotinib Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Crizotinib Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Crizotinib Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Crizotinib Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Crizotinib Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Crizotinib Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Crizotinib Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Crizotinib Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Crizotinib Capsules Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Crizotinib Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Crizotinib Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Crizotinib Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Crizotinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Crizotinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Crizotinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Crizotinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Crizotinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Crizotinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Crizotinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Crizotinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Crizotinib Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Crizotinib Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Crizotinib Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Crizotinib Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Crizotinib Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg
  • 250mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chia Tai Tianqing Pharmaceutical Group
  • Cipla Limited
  • Glenmark Pharmaceuticals
  • Natco Pharma
  • Pfizer
  • Jiangsu Hengrui Medicine
  • Qilu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crizotinib Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Crizotinib Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Crizotinib Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Crizotinib Capsules Market Dynamics
  1. 2.1 Crizotinib Capsules Industry Trends
  2. 2.2 Crizotinib Capsules Industry Drivers
  3. 2.3 Crizotinib Capsules Industry Opportunities and Challenges
  4. 2.4 Crizotinib Capsules Industry Restraints
3 Crizotinib Capsules Market by Company
  1. 3.1 Global Crizotinib Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Crizotinib Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Crizotinib Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Crizotinib Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Crizotinib Capsules Company Ranking (2024-2026)
  6. 3.6 Global Crizotinib Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Crizotinib Capsules Company Product Type and Application
  8. 3.8 Global Crizotinib Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Crizotinib Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Crizotinib Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Crizotinib Capsules Market by Type
  1. 4.1 Crizotinib Capsules Type Introduction
  2. 4.1.1 200mg
  3. 4.1.2 250mg
  4. 4.2 Global Crizotinib Capsules Sales Volume by Type
  5. 4.2.1 Global Crizotinib Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Crizotinib Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Crizotinib Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Crizotinib Capsules Sales Value by Type
  9. 4.3.1 Global Crizotinib Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Crizotinib Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Crizotinib Capsules Sales Value Share by Type (2021-2032)
5 Crizotinib Capsules Market by Application
  1. 5.1 Crizotinib Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Crizotinib Capsules Sales Volume by Application
  6. 5.2.1 Global Crizotinib Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Crizotinib Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Crizotinib Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Crizotinib Capsules Sales Value by Application
  10. 5.3.1 Global Crizotinib Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Crizotinib Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Crizotinib Capsules Sales Value Share by Application (2021-2032)
6 Crizotinib Capsules Regional Sales and Value Analysis
  1. 6.1 Global Crizotinib Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Crizotinib Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Crizotinib Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Crizotinib Capsules Sales by Region (2027-2032)
  5. 6.3 Global Crizotinib Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Crizotinib Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Crizotinib Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Crizotinib Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Crizotinib Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Crizotinib Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Crizotinib Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Crizotinib Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Crizotinib Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Crizotinib Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Crizotinib Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Crizotinib Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Crizotinib Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Crizotinib Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Crizotinib Capsules Sales Value Share by Country, 2025 VS 2032
7 Crizotinib Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Crizotinib Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Crizotinib Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Crizotinib Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Crizotinib Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Crizotinib Capsules Sales by Country (2027-2032)
  6. 7.4 Global Crizotinib Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Crizotinib Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Crizotinib Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Crizotinib Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Crizotinib Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Crizotinib Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chia Tai Tianqing Pharmaceutical Group
  2. 8.1.1 Chia Tai Tianqing Pharmaceutical Group Company Information
  3. 8.1.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
  4. 8.1.3 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio
  6. 8.1.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
  7. 8.2 Cipla Limited
  8. 8.2.1 Cipla Limited Company Information
  9. 8.2.2 Cipla Limited Business Overview
  10. 8.2.3 Cipla Limited Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Limited Crizotinib Capsules Product Portfolio
  12. 8.2.5 Cipla Limited Recent Developments
  13. 8.3 Glenmark Pharmaceuticals
  14. 8.3.1 Glenmark Pharmaceuticals Company Information
  15. 8.3.2 Glenmark Pharmaceuticals Business Overview
  16. 8.3.3 Glenmark Pharmaceuticals Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio
  18. 8.3.5 Glenmark Pharmaceuticals Recent Developments
  19. 8.4 Natco Pharma
  20. 8.4.1 Natco Pharma Company Information
  21. 8.4.2 Natco Pharma Business Overview
  22. 8.4.3 Natco Pharma Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Natco Pharma Crizotinib Capsules Product Portfolio
  24. 8.4.5 Natco Pharma Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Crizotinib Capsules Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Jiangsu Hengrui Medicine
  32. 8.6.1 Jiangsu Hengrui Medicine Company Information
  33. 8.6.2 Jiangsu Hengrui Medicine Business Overview
  34. 8.6.3 Jiangsu Hengrui Medicine Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio
  36. 8.6.5 Jiangsu Hengrui Medicine Recent Developments
  37. 8.7 Qilu Pharmaceutical
  38. 8.7.1 Qilu Pharmaceutical Company Information
  39. 8.7.2 Qilu Pharmaceutical Business Overview
  40. 8.7.3 Qilu Pharmaceutical Crizotinib Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qilu Pharmaceutical Crizotinib Capsules Product Portfolio
  42. 8.7.5 Qilu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Crizotinib Capsules Value Chain Analysis
  2. 9.1.1 Crizotinib Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Crizotinib Capsules Sales Mode & Process
  6. 9.2 Crizotinib Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Crizotinib Capsules Distributors
  9. 9.2.3 Crizotinib Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst